Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Concepta LSE:CPT London Ordinary Share GB00BYZ2R301 ORD 2.5P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 2.85p 23,191 05:00:01
Bid Price Offer Price High Price Low Price Open Price
2.70p 3.00p 2.85p 2.85p 2.85p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.11 -2.45 -2.00 5.4

Concepta (CPT) Latest News

More Concepta News
Concepta Takeover Rumours

Concepta (CPT) Share Charts

1 Year Concepta Chart

1 Year Concepta Chart

1 Month Concepta Chart

1 Month Concepta Chart

Intraday Concepta Chart

Intraday Concepta Chart

Concepta (CPT) Discussions and Chat

Concepta (CPT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:26:442.7515,718432.17O
11:09:172.757,473205.47O
View all Concepta trades in real-time

Concepta (CPT) Top Chat Posts

DateSubject
10/12/2018
08:20
Concepta Daily Update: Concepta is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker CPT. The last closing price for Concepta was 2.85p.
Concepta has a 4 week average price of 2.55p and a 12 week average price of 2.25p.
The 1 year high share price is 7.95p while the 1 year low share price is currently 2.25p.
There are currently 188,196,675 shares in issue and the average daily traded volume is 7,704 shares. The market capitalisation of Concepta is £5,363,605.24.
07/8/2018
09:00
woodcutter: There's one aspect of this share that tells you everything you need to know. They've just had a placing and Henau hasn't added to his meagre holding of less than £8K in shares. Other than the third party transactions I'd be interested to know who else has stumped up cash for the oversubscribed equity raise. Henau has presided over a complete collapse in the share price and has failed miserably to get the supply chain, production and sales functions organised to a standard capable of delivering what appears to be a decent product. It seems pretty obvious to me the most important criteria for delivering this product was to have leadership with experience of operating in China, does Henau have this? Strikes me he's not spending enough time at the coal face but sitting behind his desk in the UK He should be removed and replaced with someone with sufficient drive and investment interest to get the business moving. I'm not invested, nonetheless I've been watching with interest. At some point in the near future it will go bust if it continues in the current vein. Still on my watch list for now but something needs to develop soon. woody
29/12/2017
14:40
opodio: Anyone still following ? Share price starting to look like the usual Chinese Takeaway. 0p coming
13/11/2017
07:37
michaelmouse: There it is as predicted a hugely diluted cash raise at 7p. Slightly better price than anticipated (5p) but not by much. Bear in mind the share price was around 13p (46% discounted placing) when I alerted you to what was going on here in early July. Cash raised is £2m which won't even last a year imo. Dilution is more than a quarter of the previous share capital and a fifth of the enlarged share capital. I'd advise that you read my previous posts on this one and others that are very similar. It'll save you getting suckered in by the paid pimps pumping these loss making cash burners in their attempts to prop up the share price and line their own pockets at your expense. Aimho of course.
11/11/2017
08:30
nobilis: michaelmouse6 Nov '17 - 16:25 - 37 of 57 0 1 Nice of them to sneak out a profit warning at lunchtime:- https://uk.advfn.com/stock-market/london/concepta-CPT/share-news/Concepta-PLC-Trading-and-Order-Update/76022167 Yes naughty
06/11/2017
16:25
michaelmouse: Nice of them to sneak out a profit warning at lunchtime:- https://uk.advfn.com/stock-market/london/concepta-CPT/share-news/Concepta-PLC-Trading-and-Order-Update/76022167 "However, due to third party supplier constraints, revenues from this expected order will be realised in Q1 2018, meaning that 2017 revenues will be lower than market expectations." Oops! Posts 17, 18 and 26. hTTp://michae1mouse.blogspot.co.uk/2017/07/shares-to-avoid-at-all-costs.html hTTp://michae1mouse.blogspot.co.uk/2017/07/cash-flow-is-king.html Take a look at the respective charts of CPT, NIPT, BST and OPTI since I wrote these reports back in July, and draw your own conclusions. Opti's share price is just about managing to stand still. Today's profit warning from CPT serves as a reminder of what can and often does go wrong with these early start up companies. CPT's market cap. has and is coming down to a more sensible level now, although I seem to remember when I last looked at the accounts that it will need far more cash in the near future? Opti is on a valuation of over £50m with negligible revenues. A sitting duck I'd think. CPT, NIPT and BST have proven to be dreadful investments so far. Is Opti next in line? As ever, just my thoughts. Aimho.
01/5/2017
08:20
rubberbullets: and by the end of the year, they will have less than 12 months cash left BUT you are wrong because cash burn increased at the period end so it wlll be higher than 140,000 burn a month now This will lead to accounts being qualified. Share price will fall towards 0p as the cash runs out Who wants to fund a buisness that needs life support
01/5/2017
07:03
smart_investor: I believe Concepta will shortly go on a very strong run for the reminder of the year with a string of announcements due. I did expect this all to happen much quicker since its launch on AIM but it is what it is. The company have come a long way in a short space of time and considering the size of the company they have done very well. The market cap is now roughly £18m but I think it has big potential to be valued at well over £50m by the year end if the announcements which they say are coming, do arrive in a timely fashion. The company is now all clear to sell the product in China, just final hospital testing to be completed. Likely to get an announcement on this in the next 4 weeks. First order from China and first revenues is due and confirmation of this to the market will set things of nicely. Its a big milestone to become a revenue generating company from a research company and concepts are so so close to achieving that now. I think the market will revalue this company much higher when they can prove it is revenue generating and it has a product it can actually sell. Also good news is there looks to be plenty cash in the bank. Results say £2.7m in December. Very good considering they raised £3.5 in the placing and open offer in its AIM listing in July so there does not look to be an immediate or even short/medium term need for cash. Especially if the first revenue announcement from China is a substantial one, it will bulk up the bank balance nicely. All very good for the share price and shareholder value.
27/10/2016
15:38
smart_investor: It has been 4 months yesterday since we listed on AIM. The share price has done well and the company has progressed steadily with the New Laboratory opening in Bedfordshire and the Chinese Manufacturing agreement. We must now be on the cusp of announcing our first order to China. Shareprophets have already commented some weeks ago our product was on its the way to China. Where did they get this info from? Its not something they would just make up. So unless it is stuck in customs I assume this little AIM tiddler will be announcing revenue very shortly and it will bring a new wave of publicity to the company. Erik has kept very quiet of late in the media so lets hope he has been very busy behind the scenes and will announce something for all of us to get excited about. p.s I see deanroberthunt you managed to buy some stock on todays fall. That could be a shrewd move in the coming weeks.
12/10/2016
22:40
smart_investor: Thanks for link b3121 A joy to see the share price continue its move north - to what price one can only guess. That three month chart does look very good. Fantastic to hear the analysts backing us too! Things looking well in Camp-CPT
04/10/2016
09:58
smart_investor: For your benefit luminoso... We tipped these shares at a 12p offer - they are now 19.5p-21p but hang on tight. We aim to be selling at 25p+ very soon. But before then an urgent reminder for long term holders: warrants! Deadline 6 October. There were warrants at 7.5p handed out to those who owned shares before the RTO earlier this year. 1 warrant for every share held. The number of warrants outstanding is pretty small but given where the shares now stand it would be sheer insanity not to exercise now as the deadline is 6 October. We got our broker to exercise ours (which equated to c3.5% of the total number of warrants) last week and we remind all long term holders not to let this free money opportunity lapse. Call your broker today if you are unsure. Last week Concepta (CPT) announced that it has signed a deal with a Chinese company, Huanzhong Biotech Limited ( HZ) to to assemble and package Concepta's 'My Lotus' fertility product. My Lotus already has regulatory clearance and so this paves the way for a launch very soon indeed. In fact we believe that the first kits have already been shipped. Concepta states: HZ Biotech will exclusively assemble and package Concepta produced components (including bulk tests and electronic meters), to produce Concepta's My Lotus product to specification for the Chinese market. HZ will utilise its manufacturing site and processes, adhering to locally applicable laws and Chinese regulatory requirements. In addition to assembling the final My Lotus product, HZ Biotech will be the sole purchaser of Concepta's My Lotus product and help facilitate its launch to the Chinese market and include post-market surveillance. Concepta will also look to work with a network of distributors in China to help achieve maximum market penetration in China and will update the market on these developments in due course. Concepta's MyLotus is the only consumer product which allows both quantitative and qualitative measurements of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Ends. Concepta states that an estimated 4 million women in China each year discover that they have unexplained infertility and that as such annual revenue potential for this target market is "expected to be worth" £250m per annum. Hmmmm, poor English. We think that means that the market potential is £250 million per annum. But if My Lotus is as good as Concepta claims then it does not need much of a market share to justify a big premium to the current share price - at 19.5p the market cap is c £20 million. And that is just China. 2016 will see a launch in the PRC. In 2017 we will see launches in the UK and Europe. We expect more news on all fronts well before Christmas. You can see the potential and you can see that it is far from discounted. We are well up on the share tip ( at a 12p offer) but on this news the stance is strong hold. On this website we continue to target 25p + to sell and to target that for well before Christmas. In fact we hope to see the shares zoming past 25p very soon indeed. News of the first Chinese sales must be released very soon and we think that the RNS pipeline is pregnant with other developments. - See more at: hxxp://www.shareprophets.com/views/24191/concepta-manufacturing-deal-signed-in-china-launch-now-very-close-urgent-warrant-deadline#sthash.I3PBiX4K.dpuf
Concepta share price data is direct from the London Stock Exchange
Your Recent History
LSE
CPT
Concepta
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181210 23:43:21